{"database": "lobbying", "table": "lobbying_activities", "rows": [[3012004, "bcd3ded5-9476-4ccb-ad34-5003103db7de", "Q2", "BROWNSTEIN HYATT FARBER SCHRECK, LLP", 7257, "WALGREEN CO.", 2023, "second_quarter", "PHA", "Pharmacist provider status Issues related to drug pricing Implementation of the Inflation Reduction Act of 2022 INFORM Act Issues related to access and distribution of pharmaceutical products", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-18T18:30:42-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3012004"], "units": {}, "query_ms": 0.8069869363680482, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}